Depomed Gets Patent Win Over Generic Nucynta Drugmakers
Depomed Inc. won a major ruling Friday when a New Jersey federal judge said patents relating to its painkiller drug Nucynta are valid and that several generic drugmakers have infringed claims...To view the full article, register now.
Already a subscriber? Click here to view full article